Baxter Recalls IV Solutions
Baxter voluntarily recalls select lots of IV solutions due to possible particulate matter.
FDA reported on April 9, 2015 that Baxter International has voluntarily recalled select lots of intravenous (IV) solutions for possible particulate matter. The IV solutions include Sodium Chloride Injection, USP, indicated as a source of water and electrolytes and for use as a priming solution in hemodialysis procedures; Dextrose Injection, USP, indicated as a source of water and calories; and Lactated Ringer’s Injection, USP, indicated as a source of water and electrolytes, or as an alkalinizing agent. The recalled lots were distributed in the United States and Bermuda between Jan. 14, 2015 and March 5, 2015.
Baxter personnel discovered the particulates while performing routine maintenance and identified the particulates as material from a solution transmission system pump. The company has not yet received any adverse event reports or complaints.
A full list of recalled lots can be found on FDA’s website.
Source: FDA
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
